A Phase 1 Study Evaluating CPI-0610 in Patients With Progressive Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Lymphoma
Related studies linked through entity extraction aliases.
Pralatrexate + Romidepsin in Relapsed/Refractory Lymphoid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Rituximab + GM-CSF in Patients With Follicular B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
- Status
- COMPLETED
- Phase
- N/A
Thromboelastography, Platelet Function and Platelet Recovery in Haemato-oncologic Patients With Thrombocytopenia
- Status
- COMPLETED
- Phase
- N/A
Carfilzomib Consolidation Therapy After Autologous Stem Cell Transplantation (ASCT) for Mantle Cell Lymphoma (MCL), T-cell Lymphoma (TCL), and Diffuse Large B-Cell Lymphoma (DLBCL)
- Status
- COMPLETED
- Phase
- PHASE1
Development of a Biomarker Directed Strategy to Ameliorate Common Toxicities From Conventional Chemotherapy
- Status
- SUSPENDED
- Phase
- N/A
Lenalidomide and Ipilimumab After Stem Cell Transplant in Treating Patients With Hematologic or Lymphoid Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
PET Imaging of Cancer Patients Using [18F]-SKI-249380, a Radiolabeled Dasatinib-Derivative
- Status
- COMPLETED
- Phase
- PHASE1
Study of Brentuximab Vedotin in Participants With Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE4
Phase I Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-427 When Given to Patients With Advanced and Refractory Solid Tumors or Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
Cardiac Fibrosis by CMR in Patients With Cancer
- Status
- WITHDRAWN
- Phase
- N/A
Phase I Dose-finding and Preliminary Efficacy Study of the Istodax® in Combination With Doxil® for the Treatment of Adults With Relapsed or Refractory Cutaneous T-cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Study of Rituximab and Brentuximab Vedotin for Relapsed Classical Hodgkin Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
Food Effect Study of Alisertib (MLN8237) in Participants With Advanced Solid Tumors or Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1
Acupuncture for Chemotherapy-induced Peripheral Neuropathy
- Status
- UNKNOWN
- Phase
- NA
Evaluation of Immunological Reconstitution After Haploidentical Bone Marrow Transplantation
- Status
- UNKNOWN
- Phase
- N/A
A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Rituximab (MabThera/Rituxan) in Participants With Diffuse Large B Cell Lymphoma (DLBCL) or Follicular Lymphoma (FL)
- Status
- COMPLETED
- Phase
- PHASE3
IL-15 Super Agonist ALT-803 to Treat Relapse Of Hematologic Malignancy After Allogeneic SCT
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A RETROspective Data Collection of comPRESSion Anastomosis Using the ColonRing
- Status
- UNKNOWN
- Phase
- N/A